Nice Insight’s PharmasAlmanac.com is live! The site is a resource for both industry analysis and thought leadership from some of the life science industry’s most advanced companies and significant players.
Over the last 18 months, the Pharma’s Almanac has attracted high-level commentary and strategic analysis content from some of the industry’s most respected executives and operational experts. The online answer to the quarterly publication, PharmasAlmanac.com, is designed to be a platform that inspires opinion, ideas and collaboration. In addition to hosting articles found in print, the site will offer content exclusive to the web.
Distribution
The reach of the Pharma’s Almanac magazine, available as a supplement to the American Pharmaceutical Review (APR), is significant. APR’s network includes 67,000 BPA Worldwide readers; That’s Nice distributes to an additional 30,000 non-BPA readers and industry opinion leaders, for a total of 97,000 online readers. The online publication will no doubt increase this presence, likely more than doubling readership and unique visits.
Inbound Online Marketing
Pharma’s Almanac online, in conjunction with Nice Digital, offers the opportunity to create inbound, online marketing strategies with proven ways to selectively engage visitors with tailored, relevant content. Inbound techniques center on retaining organic visitors through automated suggestions. PharmasAlmanac.com includes News, Insights and Trends to guide readers in their experience of the site. Visitors can actively engage the site and choose increasingly selective points of access, prompted by their previous activity.
The site is intended to be a platform for companies seeking better visibility. By presenting the intrinsic value of operational and technical products and services to the market, business leads and opportunities are generated. Visitors to PharmasAlmanac.com, and readers from Pharma’s Almanac print editions, represent companies seeking — or interested in — information about understanding or overcoming operational hurdles, poor-performing equipment and other institutional or competitive challenges.
In addition to the array of articles from the past several issues, 2017 will include insights from the Nice Insight Outsourcing Surveys, including those focused on contract manufacturing and development organizations, contract research organizations, excipient suppliers, pharmaceutical equipment providers and intermediates providers, with separate surveys on supply chain and logistics, as well as Private Equity/venture capitalists. This newly sourced data will be analyzed and revisited throughout the year, to indicate both market status and overarching trends in pharma.
Get in the Conversation — Be a Contributor
If you have an area of specialty that you would like to share with our readers, you can submit article ideas directly to our editorial staff. Please refer to the Editorial
Calendar, though we accept submissions on a broad range of topics throughout the year.
